Skip to content
★ Sign in to follow
DL

Daniel Lang

Athenex, Inc.
Total declarations
2
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 19 Sept 2022 for Athenex, Inc., €1,768.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Daniel Lang: trading record in brief

This profile gathers the share dealings of Daniel Lang in Athenex, Inc. Activity is concentrated on a single trading day, 16 September 2022, with 2 filings.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 19 September 2022 came the latest disclosure, a share grant for €1,768 in Athenex, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Daniel Lang

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ◆
    Pres Cell Therapy, VP Corp DevExecutivesAthenex, Inc.
    1,766 USD30SEC
    4,323 shares@ US$0.4086100.0% of flowCommon StockSEC:0001209191-22-050508:1
  • ◇
    Pres Cell Therapy, VP Corp DevExecutivesAthenex, Inc.
    0SEC
    12,500 sharesCommon StockSEC:0001209191-22-050508:0

2 of 2 declarations